(ACL:Australian Stock Exchange Ltd)
Susan L. Kelley M.D.
Non-Executive Director, Chairman of Science & Technology Committee, Member of Remuneration Committee and Member of Nomination Committee, Alchemia Limited
|Age||Total Calculated Compensation||This person is connected to 41 board members in 4 different organizations across 4 different industries.|
See Board Relationships
Dr. Susan L. Kelley, M.D, served as the Chief Medical Officer of Multiple Myeloma Research Consortium and The Multiple Myeloma Research Foundation/Consortium from July 2008 to March 2011. Dr. Kelley is a successful oncology drug developer and has a rare breadth and depth of drug development experience. Dr. Kelley developed drugs in oncology and immunology for over 25 years. She held positions of increasing responsibility at Bristol-Myers Squibb in Oncology and Immunology ...
3 Hi –Tech Court Brisbane Technology ParkPhone: 61 7 3340 0200
Brisbane, Queensland 4113
Fax: 61 7 3340 0222
Board Members Memberships*
Director and Member of Science Committee
Non-Executive Director, Chairman of Science & Technology Committee, Member of Remuneration Committee and Member of Nomination Committee
Director and Chairman of Clinical Advisory Committee
Duke University Medical Center
Annual Compensation*There is no Annual Compensation data available.
|There is no Competitor Compensation data available.|